SM
NAUT icon

Sciencast Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Sciencast Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-63,529
Closed -$283K – 577
2022
Q1 		$283K Buy
+63,529
New +$261K 0.06% 317

Other funds holding NAUT

AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return

Sciencast Management's NAUT Position: Q2 2022 in Review

Sciencast Management sold out of Nautilus Biotechnolgy (NAUT) in Q2 2022, closing a stake of 63,529 shares — an estimated $283K sold.

Sciencast Management first reported a position in NAUT in Q1 2022 and held it in 1 quarter. The position peaked at $283K in Q1 2022. 83 funds tracked by Wall St. Rank hold NAUT as of Q2 2022.

  • Sciencast Management reported no remaining Nautilus Biotechnolgy position as of Q2 2022 after selling out during the quarter.
  • Sciencast Management sold 63,529 Nautilus Biotechnolgy shares in Q2 2022, an estimated $283K.
  • Sciencast Management first reported a position in Nautilus Biotechnolgy in Q1 2022 and held it in 1 quarter.
  • Sciencast Management's Nautilus Biotechnolgy position peaked at $283K in Q1 2022.
  • 83 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.